Not Tagged
Not Tagged
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'dance']
great session at #asco22 on ctdna chaired by . some highlights include: role of ctdna guidance in stage 2 crc presented by - reduced proportion of pts receiving adj chemo (28-&gt;15%) without compromise of 2-yr rfs (93.5 vs 92.4%). 
GI Oncologist. Director, Clinical Development at Gilead Sciences.